Not all patients with CLL involve therapy. Inspite of all recent advancements, the iwCLL continue to endorses watchful observation for people with asymptomatic ailment.86 This advice is predicated on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari masyarakat https://johnw098lzp6.blogsvila.com/profile